GLP-1 agonists are not expensive to produce, however, and the patent on Ozempic expired in January of 2026 in Canada and China (and lasts until 2030 in the U.S.), but I expect the market to bring the costs down dramatically over the next few years
Patients should be aware of the risk of diabetic retinopathy complications , particularly with semaglutide, especially in those with pre-existing retinopathy and rapid improvements in blood glucose
Many patients worry whether semaglutidea GLP-1 receptor agonistis safe to use alongside blood pressure medication
doi: 10.1016/j.ejmech.2015.01.014
Regular use of these injections may help regulate insulin sensitivity and enhance how our body controls blood sugar
Women in their late 40s and early 50s starting sermorelin often describe more dramatic improvements in sleep quality, energy, and skin compared to men of the same age, because their pre-treatment baseline was more significantly affected by the dual hormonal decline
